ER-23006

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameER-23006

Drug Alias NameER-23006

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBeta adrenergic receptors agonists

TargetsBeta adrenergic receptors

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEurapharm Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesEurapharm Inc

Active IndicationsN/A

Inactive IndicationsAsthma

ATC CodeN/A